Review Article: the limitations of corticosteroid therapy in Crohn’s disease
Review Article: non-systemic chemotherapy in the treatment of colorectal cancer—portal vein, hepatic arterial and intraperitoneal approaches
Review Article: Alternative antibacterial agents for Helicobacter pylori eradication
Review Article: balsalazide therapy in ulcerative colitis
Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger–Ellison syndrome?
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole
Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn
Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine
Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis
Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia—are central serotoninergic responses enhanced?
Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients
Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients
Acute cholangitis—predictive factors for emergency ERCP
Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience
Immune sensitization to food, yeast and bacteria in Crohn’s disease
Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study
Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor
Glicentin, an active enteroglucagon, has a significant trophic role on the small intestine but not on the colon in the rat
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats